atropine has been researched along with norfluoxetine in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (norfluoxetine) | Trials (norfluoxetine) | Recent Studies (post-2010) (norfluoxetine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 275 | 33 | 69 |
| Protein | Taxonomy | atropine (IC50) | norfluoxetine (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 9 | |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily C member 1 | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.2909 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
1 other study(ies) available for atropine and norfluoxetine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |